Yun-Hui Li

Yun-Hui Li


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2017 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
SQSi‐Yao Qu
Si‐Yao Qu
YSYuan‐Yuan Sun
Yuan‐Yuan Sun
YLYun-Hui Li
Yun-Hui Li
ZXZhen‐Ming Xu
Zhen‐Ming Xu
WFWei-Neng Fu
Wei-Neng Fu
YY1 is a key transcription factor and plays different roles in various cancers. However, role and mechanism of YY1 in laryngeal cancer are still unknown. YY1 and MYCT1 mRNA and protein levels were detected by Real‐time RT‐PCR and Western Blot methods, respectively. Binding of YY1 to MYCT1 promoter was predicted and confirmed by bioinformatics and chromatin immunoprecipitation assays, respectively. MYCT1 promoter activity was assessed by dual luciferase assay system. Laryngeal cancer cell proliferation, migration, and apoptosis were evaluated by cell viability, colony formation, cell scratch assay, transwell assay, and flow cytometry methods, respectively. YY1 and MYCT1 were upregulated and downregulated at transcriptional level in laryngeal cancer, respectively, which showed a negative correlation between YY1 and MYCT1 expression in laryngeal cancer. Significantly higher expression of YY1 and lower expression of MYCT1 were found in laryngeal cancer tissues of patients with lymphatic metastasis than those without metastasis.YY1 directly bound to MYCT1 promoter region and inhibited its promoter activity. YY1 silence had similar biological functions as MYCT1 overexpression in repressiveness of proliferation and migration, and promotion of apoptosis in laryngeal cancer cells. However, the effects of YY1 silence were recovered by MYCT1 knockdown. YY1 promotes proliferation and migration with suppression of apoptosis via directly inhibiting MYCT1 in laryngeal cancer cells, suggesting that YY1 is a useful target as a potential oncogene in laryngeal cancer development and progression.

1 March 2018 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
ZZZhao-Xiong Zhang
Zhao-Xiong Zhang
WZWan-Ni Zhang
Wan-Ni Zhang
YSYuan-Yuan Sun
Yuan-Yuan Sun
YLYun-Hui Li
Yun-Hui Li
ZXZhen-Ming Xu
Zhen-Ming Xu
WFWei-Neng Fu
Wei-Neng Fu
CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis Zhao-Xiong Zhang,1 Wan-Ni Zhang,1 Yuan-Yuan Sun,1 Yun-Hui Li,2 Zhen-Ming Xu,3 Wei-Neng Fu1 1Department of Medical Genetics, China Medical University, Shenyang, People’s Republic of China; 2Department of Laboratory Medicine, No 202 Hospital of PLA, Shenyang, People’s Republic of China; 3Department of Otolaryngology, No 463 Hospital of PLA, Shenyang, People’s Republic of China Purpose: CREB, MYCY1 and NAT10 are involved in cancer cell migration. However, the relationship between these three proteins and their role in laryngeal cancer cell migration remains unknown. Methods: Transient gene transfection was performed in laryngeal cancer cells. Bioinformatics analysis was used to predict the binding of CREB to MYCT1 promoter. Binding of CREB to the promoter of MYCT1 was monitored by luciferase reporter assay and chromatin immunoprecipitation method in vitro and in vivo, respectively. Real-time RT-PCR and Western bolt were applied to detect gene transcription and translation levels, respectively. Laryngeal cancer cell migration was assayed by transwell cham­ber experiment. Results: CREB protein expression was significantly up-regulated in laryngeal cancer tissues and associated with cancer differentiation, tumor stage, and lymphatic metasta­sis. CREB inhibits MYCT1 expression by direct binding to its promoter. Meanwhile, MYCT1 has a negative impact on the NAT10 gene expression. Furthermore, CREB promotes NAT10 expression via down-regulating the MYCT1 gene expression. In addition, contrary to MYCT1, CREB and NAT10 enhanced laryngeal cancer cell migration. MYCT1 and NAT10 significantly rescued the effects of CREB and MYCT1 on Hep2 cell migration, respectively. Conclusion: CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis, suggesting that CREB might be a potential prognostic marker in laryngeal cancer. Keywords: laryngeal cancer, CREB, MYCT1, NAT10, migration

1 October 2020 in Cellular Signalling
Verified
Journal Article
Open access
PYPeng-Jie Yue
Peng-Jie Yue
YSYuan-Yuan Sun
Yuan-Yuan Sun
YLYun-Hui Li
Yun-Hui Li
ZXZhen-Ming Xu
Zhen-Ming Xu
WFWei-Neng Fu
Wei-Neng Fu
MYCT1 has an inhibitory effect on the migration of laryngeal cancer cells, although the underlying molecular mechanism remains unknown. In this study, we aimed to explore the mechanism of MYCT1 in the epithelial-mesenchymal transition (EMT) and migration of laryngeal cancer cells. We found that MYCT1 significantly decreased the expression of miR-629-3p but increased the expression of ESRP2 in laryngeal cancer cells. The expression of miR-629-3p and ESRP2 in laryngeal cancer tissues showed significantly positive and negative correlations with patient metastasis, respectively. miR-629-3p was confirmed to repress the expression of ESRP2 by targeting its 3'UTR. SP1 was verified to be a direct transcription factor for miR-629-3p and a downstream target of MYCT1. Moreover, MYCT1 inhibited the EMT and migration of laryngeal cancer cells through the SP1/miR-629-3p/ESRP2 pathway. Taken together, our results establish a novel MYCT1 signaling pathway in the EMT and migration of laryngeal cancer cells, thus providing important insights for further studying the pathway in the diagnosis and treatment of laryngeal cancer.

20 January 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
SCSheng Chen
Sheng Chen
YSYuan-Yuan Sun
Yuan-Yuan Sun
ZZZhao-Xiong Zhang
Zhao-Xiong Zhang
YLYun-Hui Li
Yun-Hui Li
ZXZhen-Ming Xu
Zhen-Ming Xu
WFWei-Neng Fu
Wei-Neng Fu
Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway

18 February 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PWPeng-Peng Wang
Peng-Peng Wang
SDSi-Yu Ding
Si-Yu Ding
YSYuan-Yuan Sun
Yuan-Yuan Sun
YLYun-Hui Li
Yun-Hui Li
WFWei-Neng Fu
Wei-Neng Fu
MYCT1, a target of c-Myc, inhibits laryngeal cancer cell migration, but the underlying mechanism remains unclear. In the study, we detected differentially expressed genes (DEGs) from laryngeal cancer cells transfected by MYCT1 using RNA-seq (GSE123275). DEGs from head and neck squamous cell carcinoma (HNSCC) were first screened by comparison of transcription data from the Gene Expression Omnibus (GSE6631) and the Cancer Genome Atlas (TCGA) datasets using weighted gene co-expression network analysis (WGCNA). GO and KEGG pathway analysis explained the functions of the DEGs. The DEGs overlapped between GSE6631and TCGA datasets were then compared with ours to find the key DEGs downstream of MYCT1 related to the adhesion and migration of laryngeal cancer cells. qRT-PCR and Western blot were applied to validate gene expression at mRNA and protein levels, respectively. Finally, the cell adhesion, migration, and wound healing assays were to check cell adhesion and migration abilities, respectively. As results, 39 overlapping genes were enriched in the GSE6631 and TCGA datasets, and most of them revealed adhesion function. Thirteen of 39 genes including COL6 members COL6A1, COL6A2, and COL6A3 were overlapped in GSE6631, TCGA, and GSE123275 datasets. Similar to our RNA-seq results, we confirmed that COL6 is a target of MYCT1 in laryngeal cancer cells. We also found that MYCT1 inhibited the adhesion and migration of laryngeal cancer cells via COL6. These indicate that COL6 is a potential target of MYCT1 and participates the adhesion and migration of laryngeal cancer cells, which provides an important clue for further study on how MYCT1 regulating COL6 in laryngeal cancer progression.

14 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
LLLiang Luan
Liang Luan
LDLehan Du
Lehan Du
WSWenjun Shi
Wenjun Shi
YLYun-Hui Li
Yun-Hui Li
QZQuan Zhang
Quan Zhang
Bacterial biofilms are difficult to treat due to their resistance to traditional antibiotics. Although photodynamic therapy (PDT) has made significant progress in biomedical applications, most photosensitizers have poor water solubility and can thus aggregate in hydrophilic environments, leading to the quenching of photosensitizing activity in PDT. Herein, a benzoselenadiazole-containing ligand was designed and synthesized to construct the zirconium (IV)-based benzoselenadiazole-doped metal-organic framework (Se-MOF). Characterizations revealed that Se-MOF is a type of UiO-68 topological framework with regular crystallinity and high porosity. Compared to the MOF without benzoselenadiazole, Se-MOF exhibited a higher 1O2 generation efficacy and could effectively kill Staphylococcus aureus bacteria under visible-light irradiation. Importantly, in vitro biofilm experiments confirmed that Se-MOF could efficiently inhibit the formation of bacteria biofilms upon visible-light exposure. This study provides a promising strategy for developing MOF-based PDT agents, facilitating their transformation into clinical photodynamic antibacterial applications.